MorphoSys AG (MOR) Financials
MOR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 2.2 billion | 2.2 billion |
| 2023-09-30 | 2.2 billion | 2.3 billion |
| 2023-06-30 | 2.3 billion | 2.3 billion |
| 2023-03-31 | 2.4 billion | 2.3 billion |
MOR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -63.1 million | -2.2 million |
| 2023-09-30 | -37.4 million | ? |
| 2023-06-30 | -137.1 million | 11.8 million |
| 2023-03-31 | -78.1 million | 2.1 million |
MOR Net Income
No data available :(
MOR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 754.8 million | - | 13.7 million |
| 2023-09-30 | 678.6 million | - | - |
| 2023-06-30 | 730.4 million | - | 43.4 million |
| 2023-03-31 | 862.7 million | - | 45.4 million |
MOR Shares Outstanding
MOR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 763841 | 88.8 million | 47.9 million | 58.0 million |
| 2023-09-30 | 1.8 million | 66.9 million | 15.9 million | 21.1 million |
| 2023-06-30 | 111013 | 62.0 million | 18.5 million | 23.9 million |
| 2023-03-31 | 462298 | 90.5 million | 11.9 million | 18.4 million |
MOR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 65.3 million | 16.1 million |
| 2023-09-30 | 67.5 million | 16.0 million |
| 2023-06-30 | 57.8 million | 8.4 million |
| 2023-03-31 | 67.9 million | 22.9 million |
MOR
Price: $17.89
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.50 USD
P/E Ratio: 23.99
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 71900
Market Capitalization: 2.7 billion